AI is deciding
whether your
brand exists
A researcher just asked ChatGPT which suppliers to shortlist for their next project. Your name may not have come up. Not because your product is weak. Because AI discoverability - and the emerging practices of generative engine optimisation (GEO) and answer engine optimisation (AEO) - operates by different rules. And most of the biotech, diagnostics and life science sector has not read them yet.
This hub collects Strivenn's primary research, content, frameworks, and a practical AI discoverability audit. Everything you need to move from invisible to cited.
The Wild West Rules of AI Discoverability
For the first time since Google's early days, the rules of discoverability are being rewritten in real time. Most life science marketers have not noticed yet. This is where the conversation starts.
What is query fan-out and why does it mean your number-one keyword ranking no longer guarantees AI visibility? Why does AI referral traffic convert at extraordinary rates despite driving less than 1% of total site visits? And why would you be making a serious strategic error by blocking the bots?
This is the long read that maps the full terrain: crawlers, citation mechanics, on-site structure, off-site signals, recency bias, and the five steps to take now.
0.77%
155%
Growth in LLM referral traffic over 8 months, versus 24% for traditional search
34.5%
Drop in position-one click-through rate when AI Overviews appear in search results
ELRIG Drug Discovery 2025: 68% AI Optimistic
Only 7% Winning Strivenn surveyed 107 exhibitors at ELRIG Drug Discovery 2025. The numbers should give every commercial leader pause. 68% are optimistic about AI's potential. Only 7% are power users. The rest are somewhere in between - with tools but no programmes, intentions but no infrastructure.
The survey reveals the original shape of what we now call the Programme Gap: 37% had AI tools without any structured adoption. 44% cited data quality as the primary barrier. And 62% had never asked an AI to recommend companies in their own category. Among those who had? Three quarters found themselves listed.
This is where the Unconsidered Set became visible as a pattern - not a hypothesis.
Disrupt Yourself, Before The Market Does
Three months after ELRIG. A different continent. 43 exhibitors at SLAS 2026 in Boston. The same survey. The same questions. And almost identical answers.
62% had never tested their AI visibility. 44% cited data quality as the primary barrier. But one number changed dramatically: power users nearly tripled - from 6.6% at ELRIG to 18.6% at SLAS. The top of the adoption curve is beginning to pull away from the rest.
The pattern is structural. The timeline is compressing. And the companies that disrupted themselves proactively are the ones showing up in AI recommendation lists.
The question is whether you get ahead of that curve or wait for it to pass you.
6.6%
AI power users at ELRIG DD 2025, October
18.6%
AI power users at SLAS 2026, January - nearly tripled in 3 months
62%
of exhibitors never tested
their AI visibility
Separating Signal from Snake Oil in AI Search
Your agency just pitched you an Answer Engine Optimisation project. The deck was confident. Google's LLM Gemini called the aggressive version of this pitch spam. Before you redirect budget, you need to know what the evidence actually shows.
This is the strategic framing piece for the series. It cuts through agency hype using independent data and Google's own statements, calibrates the conversion claims you have probably been shown, and introduces the three frameworks that underpin everything else.
The underlying shift is real. The question is how real, how fast, and where it creates genuine commercial risk. This article gives you the tools to answer that for your own organisation.
Three patterns surfaced in Strivenn's primary research
The Unconsidered Set
The state of being absent from AI-generated consideration before you know you are absent. You do not lose the deal. You are never in the running. Applies to every biotech, diagnostics and life science tools brand operating without an AI discoverability programme.
The Programme Gap
Tool access without structured adoption produces near-zero commercial return. The pattern behind the AI maturity gap: 44% of commercial teams have AI tools and no programme to guide their use. Access is not adoption. Adoption is not advantage.
Citation Compression
AI visibility is narrowing to five dominant brands per B2B category. Unlike traditional search, which offered ten first-page positions, an AI recommendation list is far shorter. In B2B marketing terms, this is winner-takes-most - and it is already operating.
How AI Decides Who Gets Cited
You have spent years building domain authority. You rank on page one for your most important keywords. But when a researcher asks ChatGPT which suppliers to shortlist, you may not appear. Not because your content is poor. Because AI citation is not an extension of search ranking.
This article breaks down the mechanics: why brand recognition beats backlinks, what entity consistency actually means in practice, how content structure determines extractability, and why platform presence multiplies your citation probability.
Specific, actionable, evidence-backed. For the team responsible for making it happen.
2.3X
More citations earned by self-contained content chunks of 50-150 words versus flowing narrative prose
37%
Increase in citation rates for pages that include specific statistics and pull quotes
2.8X
Your Scientific Credibility Is an AI Search Weapon
In health and science domains, AI models do not behave like consumer search. Reddit, YouTube, LinkedIn - the platforms most brand managers optimise for - barely register in AI citation analysis for technical queries. NIH content accounts for approximately 39% of AI citations in health and science. ScienceDirect: 11.5%.
The platforms your scientists have been contributing to for years are the ones AI models prefer. Most life science marketing teams are not connecting these dots.
This article makes the case that your peer-reviewed publications, named expert authorship, and ungated scientific claims are structural AI citation magnets. The window to exploit that advantage is narrowing as Citation Compression sets in.
BLOG POST COMING SOON
39%
of AI citations in health and science searches go to NIH content. Social platforms barely register.
94%
of B2B buyers now use LLMs during the buying process - peaking mid-journey during comparison and RFP drafting
6sense B2B Buyer Experience Report ↗
35%
Improvement in AI citation likelihood from entity-driven, consistently attributed content
The AI Discoverability Audit for Life Science Brands
Six phases. No specialist agency required. This is the operational guide that turns everything above into a specific action list - prioritised by impact and designed for your existing team.
-
Phase 1: Entity audit across six platforms.
-
Phase 2: Content accessibility and gated content strategy.
-
Phase 3: Technical configuration and bot access.
-
Phase 4: Content structure scoring for ten high-value pages.
-
Phase 5: Citation monitoring across five AI platforms.
-
Phase 6: Freshness cadence that keeps you retrievable.
The most important output is not the score. It is the habit of measurement. The companies with the clearest picture of where they stand will respond faster to every shift that follows.
BLOG POST COMING SOON
Ready to move from
invisible to cited?
The audit tells you where you stand. Strivenn's AI-powered inbound marketing systems help you close the gap. We combine entity strategy, structured content programmes, citation monitoring, and HubSpot implementation to build the infrastructure that earns life science, biotech and diagnostics brands a place in AI-generated consideration - consistently, not occasionally.
This is not agency retainer work. It is a structured AI maturity programme with measurable milestones and a clear commercial logic.
Exactly what the Programme Gap demands.
- A structured AI discoverability programme with measurable milestones - not a one-off audit
- Entity consistency audit across your website, LinkedIn, Crunchbase, and Wikidata
- Content restructuring for AI extraction - self-contained, schema-marked, attributed
- Named expert profiling to make your scientists AI-citable, not just credible
- Monthly citation monitoring across ChatGPT, Perplexity, Google AI Mode, Copilot, and Claude
- HubSpot implementation connecting AI visibility to inbound pipeline